Tumor necrosis factor mediates hepatic growth hormone resistance during sepsis

American Journal of Physiology - Endocrinology and Metabolism

Volumn 283, Issue 3 46-3, 2002, Pages

  Yumet, Gladys ^a   Shumate, Margaret L ^a   Bryant, Patrick ^a   Lin, Cheng Mao ^b   Lang, Charles H ^a   Cooney, Robert N ^a,b  

^a PENN STATE COLLEGE OF MEDICINE   (United States)

^b PENNSYLVANIA STATE UNIVERSITY   (United States)

Author keywords

Growth hormone insulin like growth factor I axis; Hepatocytes; Janus kinase signal transducer and activator of transcription signaling; Tumor necrosis factor

Indexed keywords

GROWTH HORMONE; JANUS KINASE; MUSCLE PROTEIN; SOMATOMEDIN C; TUMOR NECROSIS FACTOR ALPHA;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; GENE TARGETING; HORMONAL REGULATION; HORMONE RESISTANCE; LIVER METABOLISM; MEMBRANE BINDING; NITROGEN BALANCE; NONHUMAN; PRIORITY JOURNAL; PROTEIN DEGRADATION; PROTEIN PHOSPHORYLATION; PROTEIN SYNTHESIS INHIBITION; RAT; SEPSIS; SIGNAL TRANSDUCTION;

EID: 0036710386     PISSN: 01931849     EISSN: None     Source Type: Journal    
DOI: 10.1152/ajpendo.00107.2002     Document Type: Article

References (56)

1. Adamo ML, Neuenschwander S, and LeRoith D. Structure, expression, and regulation of the IGF-I gene. In: Current Directions in Insulin-Like Growth Factor Research, edited by D Le-Roith and MK Raisada. New York: Plenum, 1994, p. 1-11.
2. Alves dos Santos CM, van Kerkhof P, and Strous GJ. The signal transduction of the growth hormone receptor is regulated by the ubiquitin/proteasome system and continues after endocytosis. J Biol Chem 276: 10839-10846, 2001.
3. Bergad PL, Schwarzenberg SJ, Humbert JT, Morrison M, Amarasinghe S, Towle HC, and Berry SA. Inhibition of growth hormone action in models of inflammation. Am J Physiol Cell Physiol 279: C1906-C1917, 2000.
4. Boisclair YR, Wang J, Shi J, Hurst KR, and Oii GT. Role of the suppressor of cytokine signaling-3 in mediating the inhibitory effects of interleukin-1B on the growth hormone-dependent transcription of the acid-labile subunit gene in liver cells. J Biol Chem 275: 3841-3847, 2000.
5. Carter R, Yumet G, Pena A, Soprano DR, and Soprano KJ. Transcriptional regulation of c-Jun expression during late G1/S in normal human cells is lost in human tumor cells. Oncogene 9: 2675-2682, 1994.
6. Cerra FB, Siegel JH, Coleman B, Border JR, and McMenamy RR. Septic autocannibalism: A failure of exogenous nutritional support. Ann Surg 192: 570-580, 1980.
7. Chow JC, Ling PR, Qu Z, Laviola L, Ciccarone A, Bistrian BR, and Smith RJ. Growth hormone stimulates tyrosine phosphorylation of JAK2 and STAT5 but not insulin response substrate-1 or SHC proteins in liver and skeletal muscle of normal rats in vivo. Endocrinology 137: 2880-2886, 1996.
8. Colson A, Le Cam A, Maiter D, Ederly M, and Thiessen J. Potentiation of growth hormone-induced liver suppressors of cytokine signaling messenger ribonucleic acid by cytokines. Endocrinology 141: 3687-3695, 2000.
9. Cooney RN, Iocono J, Maish GO, Smith JS, and Ehrlich P. Tumor necrosis factor mediates impaired wound healing in chronic abdominal sepsis. J Trauma 42: 415-420, 1997.
10. Cooney RN, Kimball SR, and Vary TC. Regulation of skeletal muscle protein turnover in sepsis: Mechanisms and mediators. Shock 7: 1-16, 1997.
11. Cooney RN, Vary TC, Maish GO, Shumate ML, and Eckman R. TNF binding protein ameliorates alterations in skeletal muscle protein metabolism during sepsis. Am J Physiol Endocrinol Metab 276: E611-E619, 1999.
12. Dahn MS and Lange MP. Systemic and splanchnic metabolic response to exogenous growth hormone. Surgery 123: 528-38, 1998.
13. Dahn MS, Lange MP, and Jacobs LA. Insulin-like growth factor I production is inhibited in human sepsis. Arch Surg 123: 1409-1414, 1988.
14. Davey HW, Xie T, McLachlan MJ, Wilkins RJ, Waxman DJ, and Grattan DR. STAT5b is required for GH-induced liver IGF-I gene expression. Endocrinology 142: 3836-3841, 2001.
15. Defalque D, Brandt N, Ketelslegers JM, and Thissen JP. GH insensitivity induced by endotoxin injection is associated with decreased liver GH receptors. Am J Physiol Endocrinol Metab 276: E565-E572, 1999.
16. Denson LA, Menon RK, Shaufl A, Bawa HS, Williams CR, and Karpen SJ. TNF-α downregulates murine hepatic growth hormone receptor expression by inhibiting Sp1 and Sp3 binding. J Clin Invest 107: 1451-1458, 2001.
17. Fan J, Char D, Bagby GJ, Gelato MC, and Lang CH. Regulation of insulin-like growth factor-I (IGF-I) and IGF-binding proteins by tumor necrosis factor. Am J Physiol Regul Integr Comp Physiol 269: R1204-R1212, 1995.
18. Fan J, Molina PE, Gelato MC, and Lang CH. Differential tissue regulation of insulin-like growth factor-I content and binding proteins after endotoxin. Endocrinology 134: 1685-1692, 1994.
19. Fan J, Wojnar M, Theodorakis M, and Lang CH. Regulation of insulin-like growth factor (IGF-I) mRNA and peptide, and IGF-binding proteins by interleukin-1. Am J Physiol Regul Integr Comp Physiol 270: R621-R629, 1996.
20. Frost RA and Lang CH. Growth factors in critical illness: Regulation and therapeutic aspects. Curr Opin Clin Nutr Metab Care 1: 195-205, 1998.
21. Gebert CA, Park SH, and Waxman DJ. Regulation of signal transducer and activator of transcription (STAT) 5b activation by the temporal pattern of growth hormone stimulation. Mol Endocrinol 11: 400-414, 1997.
22. Gebert CA, Park SH, and Waxman DJ. Termination of growth hormone pulse-induced STAT5b signaling. Mol Endocrinol 13: 38-56, 1999.
23. Goodman MN. Interleukin-6 induces skeletal muscle protein breakdown in rats. Proc Soc Exp Biol Med 205: 182-185, 1994.
24. Hansen JA, Lindberg K, Hilton DJ, Nielsen JH, and Billestrup N. Mechanism of inhibition of growth hormone receptor signaling by suppressor of cytokine signaling proteins. Mol Endocrinol 13: 1832-1843, 1999.
25. Herrington J and Carter-Su C. Signaling pathways activated by the growth hormone receptor. Trends Endocrinol Metab 12: 252-257, 2001.
26. Herrington J, Smit LS, Schwartz J, and Carter-Su C. The role of STAT protein in growth hormone signaling. Oncogene 19: 2585-2597, 2000.
27. Jiang H and Lucy MC. Variants of the 5′-untranslated region of the bovine growth hormone receptor mRNA: Isolation, expression and effects on translational efficiency. Gene 265: 45-53, 2001.
28. Jenkins RC and Ross RJ. Acquired growth hormone resistance in adults. Baillieres Clin Endocrinol Metab 12: 315-329, 1998.
29. Jones JI and Clemmons DR. Insulin-like growth factors and their binding proteins: Biological actions. Endocr Rev 16: 3-32, 1995.
30. Jurasinski CV and Vary TC. Insulin-like growth factor-I accelerates protein synthesis in skeletal muscle during sepsis. Am J Physiol Endocrinol Metab 269: E977-E981, 1995.
31. Kempe KC, Isom HC, and Greene FE. Responsiveness of an SV40-immortalized hepatocyte cell line to growth hormone. Biochem Pharmacol 49: 1091-1098, 1995.
32. Krebs DL and Hilton DJ. SOCS: physiological suppressors of cytokine signaling. J Cell Sci 113: 2813-2819, 2000.
33. Lang CH, Fan J, Cooney RN, and Vary TC. IL-1ra attenuates sepsis-induced alterations in the IGF system and protein synthesis. Am J Physiol Endocrinol Metab 270: E430-E437, 1996.
34. Li YP and Reid MB. NF-κB mediates the protein loss induced by TNF-α in differentiated skeletal muscle myotubes. Am J Physiol Regul Integr Comp Physiol 279:R1165-R1170, 2000.
35. Li YH, Fan J, and Lang CH. Differential role of glucocorticoids in mediating endotoxin-induced changes in IGF-I and IGFBP-1. Am J Physiol Regul Integr Comp Physiol 272: R1990-R1997, 1997.
36. Liao WS, Ma KT, Wodworth CD, Mengel L, and Isom HC. Stimulation of acute-phase response in simian virus 40-hepatocyte cell lines. Mol Cell Biol 9: 2779-2786, 1989.
37. Mao Y, Ling P, Fitzgibbons TP, McCowen KC, Frick GP, Bistrian BR, and Smith RJ. Endotoxin-induced inhibition of growth hormone receptor signaling in rat liver in vivo. Endocrinology 140: 5505-5515, 1999.
38. Matthews LS, Enberg B, and Norstedt G. Regulation of rat growth hormone receptor gene expression. J Biol Chem 264: 9905-9919, 1989.
39. Moldawer LL, Svaninger G, Gerlin J, and Lundolm KG. Interleukin-1 and tumor necrosis factor do not regulate protein balance in skeletal muscle. Am J Physiol Cell Physiol 253: C766-C773, 1987.
40. Pallares-Trujillo J, Carbo N, Lopez-Soriano FJ, and Argiles JM. Does the mechanism responsible for TNF-mediated insulin resistance involve the proteasome? Med Hypotheses 54: 565-569, 2000.
41. Pellegrini S and Dusanter-Fourt I. The structure, regulation and function of the Janus kinases (JAKs) and the signal transducers and activators of transcription (STATs). Eur J Biochem 248: 615-633, 1997.
42. Posner B, Kelly PA, Shiu PC, and Friesen HG. Studies of insulin, growth hormone, and prolactin binding: Tissue distribution, species variation, and characterization. Endocrinology 95: 521-531, 1974.
43. Ram PA, Park S, Choi HK, and Waxman DJ. Growth hormone activation of Stat 1, Stat 3, and Stat 5 in rat liver. J Biol Chem 271: 5929-5960, 1996.
44. Ram PA and Waxman DJ. Interaction of growth hormone-activated STATs with SH2-containing phosphotyrosine phosphatase SHP-1 and nuclear JAK2 tyrosine kinase. J Biol Chem 272:17694-17702, 1997.
45. Sadeghi H, Wang BS, Lumanglas AL, Logan JS, and Baumbach WR. Identification of the origin of rat growth hormone binding protein in rat serum. Mol Endocrinol 4: 1799-1805, 1990.
46. Shimatsu A and Rotwein P. Sequence of two rat insulin-like growth factor 1 mRNAs differing within the 5′ untranslated region. Nucleic Acids Res 15: 7196, 1987.
47. Stein B, Rahmsdorf HJ, Steffen A, Litfin M, and Herrlich P. UV-induced DNA damage is an intermediate step in UV-induced expression of human immunodeficiency virus type 1, collagenase, c-fos, and metallothionein. Mol Cell Biol 9: 5169-5181, 1989.
48. Svanberg E, Frost RA, Lang CH, Isgaard J, Jefferson LS, Kimball SR, and Vary TC. IGF-I/IGFBP-3 binary complex modulates sepsis-induced inhibition of protein synthesis in skeletal muscle. Am J Physiol Endocrinol Metab 279:E1145-E1158, 2000.
49. Thissen JP and Verniers J. Inhibition by interleukin-1 beta and tumor necrosis factor-alpha of the insulin-like growth factor I messenger ribonucleic acid response to growth hormone in rat hepatocyte primary culture. Endocrinology 138: 1078-1084, 1997.
50. Vary TC, Voisin L, and Cooney RN. Regulation of peptidechain initiation in muscle during sepsis by interleukin-1 receptor antagonist. Am J Physiol Endocrinol Metab 271: E513-E520, 1996.
51. Wilmore D. Catabolic illnesses: Strategies for enhancing recovery. N Engl J Med 325: 695-702, 1991.
52. Wilson M, Blum R, Dandona P, and Mousa S. Effects in humans of intravenously administered endotoxin on soluble cell-adhesion molecule and inflammatory markers: A model of human diseases. Clin Exp Pharmacol Physiol 28: 376-380, 2001.
53. Woodworth CD and Isom HC. Regulation of albumin gene expression in a series of rat hepatocyte cell lines immortalized by simian virus 40 and maintained in chemically defined medium. Mol Cell Biol 7: 3740-3748, 1987.
54. Zamir O, Hasselgren PO, Kunkel SL, Frederick JA, Higashiguchi T, and Fischer JE. Evidence that tumor necrosis factor participates in the regulation of muscle proteolysis during sepsis. Arch Surg 127: 170-179, 1992.
55. Zamir O, Hasselgren PO, O'Brien WO, Thompson RC, and Fischer JE. Muscle protein breakdown during endotoxemia in rats and after treatment with IL-1ra. Ann Surg 216: 381-387, 1992.
56. Zhu T, Goh ELK, Graichen R, Ling L, and Lobie PE. Signal transduction via the growth hormone receptor. Cell Signal 13: 599-616, 2001.